China approves inhaled CanSino vaccine for clinical trials
Biden’s choice and FDA’s loosening standards of evidence
23 March 2021CRISPR study identifies gene that plays key role in metastasis of cancers to the lungs
23 March 2021China approves inhaled CanSino vaccine for clinical trials
China’s drug authority has approved for clinical trials an inhaled COVID-19 vaccine co-developed by domestic firm CanSino Biologics, the company said in a filing on Tuesday.
